Cardiovascular morbidity and mortality in patients with aortic valve sclerosis: A systematic review and meta-analysis

Matteo Nicola Dario Di Minno, Alessandro Di Minno, Pasquale Ambrosino, Paola Songia, Mauro Pepi, Elena Tremoli, Paolo Poggio

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Aims: The association between aortic valve sclerosis (AVSc) and cardiovascular (CV) events is not consistent among different studies. We have performed a meta-analysis evaluating the association between AVSc and fatal and/or non-fatal CV and cerebrovascular events. Methods and results: A systematic search was performed in the electronic databases (PubMed, Web of Science, Scopus, EMBASE). Studies evaluating coronary artery disease (CAD), stroke and CV mortality in AVSc patients and controls were included. Differences among cases and controls were expressed as Odds Ratio (OR) with pertinent 95% Confidence Intervals (CI). Thirty-one studies on 10,537 AVSc patients and 25,005 controls were included in the final analysis. The absolute risk of CAD was 45.8% (95% CI: 32.9–59.3) in AVSc patients and 29.4% (95% CI: 21.8–38.5) in controls with an OR of 2.02 (95% CI: 1.67–2.44) and an attributable risk of 35.8%. Moreover, stroke was reported in 11.8% (95% CI: 4.4–27.7) of AVSc patients and 7.9% (95% CI: 2.5–22.7) of controls (OR: 1.41, 95% CI: 1.16–1.71) with an attributable risk of 33.0%. CV mortality was 6.2% (95% CI: 2.7–13.5) in AVSc patients and 2.0% (95% CI: 0.5–7.9) in controls (OR: 2.70, 95% CI: 1.45–5.01), with an attributable risk of 67.7%. Results were confirmed when pooling together ORs for CAD, stroke and CV mortality obtained by means of multivariate analysis. Conclusions: AVSc is associated with CAD, stroke and CV mortality. Taken together, these data suggest that patients with AVSc may benefit from a stricter CV risk monitoring and that AVSc screening may be included in the frame of CV risk stratification protocols.

Original languageEnglish
Pages (from-to)138-144
Number of pages7
JournalInternational Journal of Cardiology
Volume260
DOIs
Publication statusPublished - Jun 1 2018

Fingerprint

Sclerosis
Aortic Valve
Meta-Analysis
Confidence Intervals
Morbidity
Mortality
Coronary Artery Disease
Odds Ratio
Myocardial Infarction
PubMed
Multivariate Analysis
Stroke
Databases

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Cardiovascular morbidity and mortality in patients with aortic valve sclerosis : A systematic review and meta-analysis. / Di Minno, Matteo Nicola Dario; Di Minno, Alessandro; Ambrosino, Pasquale; Songia, Paola; Pepi, Mauro; Tremoli, Elena; Poggio, Paolo.

In: International Journal of Cardiology, Vol. 260, 01.06.2018, p. 138-144.

Research output: Contribution to journalArticle

@article{045e51b2572a4299ac6e54528732f99b,
title = "Cardiovascular morbidity and mortality in patients with aortic valve sclerosis: A systematic review and meta-analysis",
abstract = "Aims: The association between aortic valve sclerosis (AVSc) and cardiovascular (CV) events is not consistent among different studies. We have performed a meta-analysis evaluating the association between AVSc and fatal and/or non-fatal CV and cerebrovascular events. Methods and results: A systematic search was performed in the electronic databases (PubMed, Web of Science, Scopus, EMBASE). Studies evaluating coronary artery disease (CAD), stroke and CV mortality in AVSc patients and controls were included. Differences among cases and controls were expressed as Odds Ratio (OR) with pertinent 95{\%} Confidence Intervals (CI). Thirty-one studies on 10,537 AVSc patients and 25,005 controls were included in the final analysis. The absolute risk of CAD was 45.8{\%} (95{\%} CI: 32.9–59.3) in AVSc patients and 29.4{\%} (95{\%} CI: 21.8–38.5) in controls with an OR of 2.02 (95{\%} CI: 1.67–2.44) and an attributable risk of 35.8{\%}. Moreover, stroke was reported in 11.8{\%} (95{\%} CI: 4.4–27.7) of AVSc patients and 7.9{\%} (95{\%} CI: 2.5–22.7) of controls (OR: 1.41, 95{\%} CI: 1.16–1.71) with an attributable risk of 33.0{\%}. CV mortality was 6.2{\%} (95{\%} CI: 2.7–13.5) in AVSc patients and 2.0{\%} (95{\%} CI: 0.5–7.9) in controls (OR: 2.70, 95{\%} CI: 1.45–5.01), with an attributable risk of 67.7{\%}. Results were confirmed when pooling together ORs for CAD, stroke and CV mortality obtained by means of multivariate analysis. Conclusions: AVSc is associated with CAD, stroke and CV mortality. Taken together, these data suggest that patients with AVSc may benefit from a stricter CV risk monitoring and that AVSc screening may be included in the frame of CV risk stratification protocols.",
author = "{Di Minno}, {Matteo Nicola Dario} and {Di Minno}, Alessandro and Pasquale Ambrosino and Paola Songia and Mauro Pepi and Elena Tremoli and Paolo Poggio",
year = "2018",
month = "6",
day = "1",
doi = "10.1016/j.ijcard.2018.01.054",
language = "English",
volume = "260",
pages = "138--144",
journal = "International Journal of Cardiology",
issn = "0167-5273",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Cardiovascular morbidity and mortality in patients with aortic valve sclerosis

T2 - A systematic review and meta-analysis

AU - Di Minno, Matteo Nicola Dario

AU - Di Minno, Alessandro

AU - Ambrosino, Pasquale

AU - Songia, Paola

AU - Pepi, Mauro

AU - Tremoli, Elena

AU - Poggio, Paolo

PY - 2018/6/1

Y1 - 2018/6/1

N2 - Aims: The association between aortic valve sclerosis (AVSc) and cardiovascular (CV) events is not consistent among different studies. We have performed a meta-analysis evaluating the association between AVSc and fatal and/or non-fatal CV and cerebrovascular events. Methods and results: A systematic search was performed in the electronic databases (PubMed, Web of Science, Scopus, EMBASE). Studies evaluating coronary artery disease (CAD), stroke and CV mortality in AVSc patients and controls were included. Differences among cases and controls were expressed as Odds Ratio (OR) with pertinent 95% Confidence Intervals (CI). Thirty-one studies on 10,537 AVSc patients and 25,005 controls were included in the final analysis. The absolute risk of CAD was 45.8% (95% CI: 32.9–59.3) in AVSc patients and 29.4% (95% CI: 21.8–38.5) in controls with an OR of 2.02 (95% CI: 1.67–2.44) and an attributable risk of 35.8%. Moreover, stroke was reported in 11.8% (95% CI: 4.4–27.7) of AVSc patients and 7.9% (95% CI: 2.5–22.7) of controls (OR: 1.41, 95% CI: 1.16–1.71) with an attributable risk of 33.0%. CV mortality was 6.2% (95% CI: 2.7–13.5) in AVSc patients and 2.0% (95% CI: 0.5–7.9) in controls (OR: 2.70, 95% CI: 1.45–5.01), with an attributable risk of 67.7%. Results were confirmed when pooling together ORs for CAD, stroke and CV mortality obtained by means of multivariate analysis. Conclusions: AVSc is associated with CAD, stroke and CV mortality. Taken together, these data suggest that patients with AVSc may benefit from a stricter CV risk monitoring and that AVSc screening may be included in the frame of CV risk stratification protocols.

AB - Aims: The association between aortic valve sclerosis (AVSc) and cardiovascular (CV) events is not consistent among different studies. We have performed a meta-analysis evaluating the association between AVSc and fatal and/or non-fatal CV and cerebrovascular events. Methods and results: A systematic search was performed in the electronic databases (PubMed, Web of Science, Scopus, EMBASE). Studies evaluating coronary artery disease (CAD), stroke and CV mortality in AVSc patients and controls were included. Differences among cases and controls were expressed as Odds Ratio (OR) with pertinent 95% Confidence Intervals (CI). Thirty-one studies on 10,537 AVSc patients and 25,005 controls were included in the final analysis. The absolute risk of CAD was 45.8% (95% CI: 32.9–59.3) in AVSc patients and 29.4% (95% CI: 21.8–38.5) in controls with an OR of 2.02 (95% CI: 1.67–2.44) and an attributable risk of 35.8%. Moreover, stroke was reported in 11.8% (95% CI: 4.4–27.7) of AVSc patients and 7.9% (95% CI: 2.5–22.7) of controls (OR: 1.41, 95% CI: 1.16–1.71) with an attributable risk of 33.0%. CV mortality was 6.2% (95% CI: 2.7–13.5) in AVSc patients and 2.0% (95% CI: 0.5–7.9) in controls (OR: 2.70, 95% CI: 1.45–5.01), with an attributable risk of 67.7%. Results were confirmed when pooling together ORs for CAD, stroke and CV mortality obtained by means of multivariate analysis. Conclusions: AVSc is associated with CAD, stroke and CV mortality. Taken together, these data suggest that patients with AVSc may benefit from a stricter CV risk monitoring and that AVSc screening may be included in the frame of CV risk stratification protocols.

UR - http://www.scopus.com/inward/record.url?scp=85044768941&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044768941&partnerID=8YFLogxK

U2 - 10.1016/j.ijcard.2018.01.054

DO - 10.1016/j.ijcard.2018.01.054

M3 - Article

C2 - 29622430

AN - SCOPUS:85044768941

VL - 260

SP - 138

EP - 144

JO - International Journal of Cardiology

JF - International Journal of Cardiology

SN - 0167-5273

ER -